Skip to content

Clinical trials

Observational Splenomegaly trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Splenomegaly Phase: Observational Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20071
20101
20152
20161
20183
20201
20211
20232
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Withdrawn3
Unknown status2
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CENTOGENE GmbH Rostock3
Fundación Española de Hematología y Hemoterapía2
Sanofi2
Central Hospital, Nancy, France1
Istanbul University1
Jewish General Hospital1
National Human Genome Research Institute (NHGRI)1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
National Institutes of Health Clinical Center (CC)1
Shanghai Zhongshan Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Splenomegaly15
Gaucher Disease5
Hepatomegaly3
Niemann-Pick Diseases3
Hypertension, Portal2
Carcinoma, Hepatocellular1
Colorectal Neoplasms1
Cystic Fibrosis1
Erdheim-Chester Disease1
Familial Mediterranean Fever1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.